Portfolio news 0

Oxford Nanopore Technologies plc

Oxford Nanopore announces senior leadership changes

Genomics plc

New study from Genomics indicates individuals who have a genetic predisposition for high BMI may require tailored approaches to tackle obesity

Oxford Nanopore Technologies plc

New strategic partnership between UK Biobank, Genomics England, NHS England and Oxford Nanopore

Ieso Digital Health Ltd

ieso Digital Health Appoints Kent Tangen as New CEO to Drive Digital Mental Health Innovation in the United States

Diffblue Ltd

Diffblue Secures $6.3 Million in New Funding Amidst 3x Growth Period

Oxa

Oxa Unveils Autonomous Ford E-Transit Van and Minibus

Kynos Therapeutics Ltd

Dr. Falk Pharma acquires Kynos Therapeutics, adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio

Alimetry Limited

Alimetry raises US$18m for next phase of growth

Akamis Bio

Akamis Bio Announces Publication Detailing Initial Proof of Mechanism for NG-350A, an IV-Dosed Tumor Gene Therapy Delivering a CD40 Agonist Payload

Quantum Dice

Quantum Dice and SCI Semiconductor announce partnership to bring quantum-backed cryptography to advanced security systems